World Health Organization

WHO launches a global database for aDSM

The Global TB Programme and the Special Programme for Research and Training in Tropical Diseases at the World Health Organization launch a global database for active TB drug safety monitoring and management (aDSM). Countries are now invited to contribute data to the global database.

Read More →

Global TB report 2016

WHO report warns global actions and investments to end TB epidemic are falling far short.

Read More →

WHO launches Target Regimen Profiles for TB treatment

The new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

Read More →

WHO recommends new TB test

Robust, rapid DNA-based test can serve as an alternative to sputum smear microscopy.

Read More →

New survey investigates levels of resistance to essential TB drugs

Geneva, 11 July 2016 – The first ever multi-country population-based survey investigating levels of the resistance to essential tuberculosis (TB) drugs was published last week in The Lancet Infectious Diseases. This work was led by the World Health Organization (WHO), in collaboration with National TB Programmes, National TB Reference Laboratories and Supranational Reference Laboratories.

Read More →

WHO Global Civil Society Task Force on TB formed

The World Health Organization’s Global TB Program has established a Global Civil Society Task Force on TB to enhance the engagement of communities, non-governmental and other civil society organizations in the implementation of the End TB Strategy.

Read More →

WHO confirms antiretroviral therapy reduces the risk of life-threatening HIV-related infections

20 June 2016 - Adults and children with HIV who start antiretroviral therapy (ART) as early as possible reduce their risk of developing serious HIV-related infections, according to new findings published in the journal Clinical Infectious Diseases on 15 June 2016.

Read More →

Frequently asked questions on shorter MDR-TB regimen

The World Health Organization (WHO)'s Global TB Program has released Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under programmatic conditions.

Read More →

Vacancy: Consultant post for the TB/HIV and community engagement unit of Global TB Programme of WHO

The TB/HIV and community engagement unit of the World Health Organization (WHO)’s Global TB Programme focuses on development of relevant policies and strategies, guidelines and tools to address (1) HIV-associated TB (2) latent tuberculosis infection (3) integrated community-based TB activities including through effective engagement of nongovernmental and other civil society organizations, and (4) integration of TB prevention, treatment and care services to maternal, neonatal and child health services.

Read More →

WHO launches The Essentials to help guide implementation of the End TB Strategy

The World Health Organization’s Global TB Programme has developed operational guidance, The Essentials, for effective adaptation and implementation of the End TB Strategy.

Read More →

Page 2 of 8 · Total posts: 10

←First 1 2 3 Last→